Abstract: Injections for treating and preventing diseases classified as any of grade 1 to 3 according to the ICRS classification of osteoarthritis, diseases classified as any of grade 1 to 3 according to the Kellgren-Lawrence classification of osteoarthritis or diseases classified as any of grade 1 to 3 according to the Outerbridge classification of osteoarthritis contain anti-Fas IgM antibody as an active ingredient and a pharmaceutically acceptable carrier to alleviate osteoarthritis symptoms by inhibiting the production of cartilage matrix degrading enzymes and by increasing the production of cartilage matrix.

Abstract: A pharmaceutical composition for the treatment of fibromyalgia, which includes pilocarpine or a pharmacologically acceptable salt thereof. The pharmaceutical composition can be used as a novel therapeutic agent for fibromyalgia.

Abstract: A method for treatment of disease classified as any of grade 1 to 3 according to the ICRS classification of osteoarthritis, any of grade 1 to 3 according to the Kellgren-Lawrence classification of osteoarthritis, or any of grade 1 to 3 according to the Outerbridge classification of osteoarthritis, the method includes a step of administrating an agent containing an anti-Fas IgM antibody as an active ingredient.

Abstract: The disclosure concerns a hard multi-ply laminate, at least two of the plies comprising primarily wood fibers compressed with a plastic, and an intermediate ply of a different chemical composition than the wood fiber plies, and top and bottom plies of substantially the same physical performances to avoid warping. An adhesive is applied between each of the plies and all the plies are compressed to form a hard laminate. An edge of the resulting board is shaped to form an artistic configuration, and the edges are coated with a moisture barrier. Thus the resulting hard laminate boards with a sculpted edge can be used directly for table and desk tops, shelving and the like without the addition of an edging strip.